Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
about
Inherited susceptibility for aggressive prostate cancerGenome-wide association study identifies new prostate cancer susceptibility lociA genome-wide search for loci interacting with known prostate cancer risk-associated genetic variantsGenome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Prognostic and predictive biomarkers: tools in personalized oncology.Characterizing genetic risk at known prostate cancer susceptibility loci in African AmericansAssociation of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.Multiplexed electrochemical protein detection and translation to personalized cancer diagnosticsInherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancerFine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk predictionProstate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examinationImpact of genotyping on outcome of prostatic biopsies: a multicenter prospective study.Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.Genome-wide association study of prostate cancer mortalityHuman polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.Two susceptibility loci identified for prostate cancer aggressiveness.Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Screening for familial and hereditary prostate cancer.Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Genetics of asthma susceptibility and severityEvaluating genetic risk for prostate cancer among Japanese and Latinos.HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC).Genome-wide two-locus epistasis scans in prostate cancer using two European populationsWhole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.Using graded response model for the prediction of prostate cancer risk.Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.The influence of family history on prostate cancer risk: implications for clinical management.Current status of genome-wide association studies in cancer.Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Nuclear morphometry, nucleomics and prostate cancer progressionGenome-wide association studies on prostate cancer: the end or the beginning?
P2860
Q27001297-8A683681-0F83-4757-A229-B67BB69DE1E9Q28924380-4F481DA4-BB6C-49A8-9940-E58106E3F4CAQ28943269-BE5C2577-1F3F-4E77-8056-3BC415A9CCC3Q30500998-E2F39419-15FE-4419-A60F-E9FAA491AD73Q30504100-22F5CED3-2ED7-45CD-9942-C247BD7BCB5BQ33651583-3581217D-FCC2-409D-9E4D-B148E2BE31A7Q33921139-39A79267-6E40-4D6E-BBF7-C31DE8C8A0AAQ34225923-3A99E6A2-0CB9-4C40-A44D-84A596E72D47Q34342253-567D51CD-151E-4072-9DFD-EFD39EAE12BBQ34511194-551D5C1A-3B90-40B7-8148-7485D4A253B3Q34524949-3D3F5B49-A50A-49DC-B67E-B5B259F6A6C3Q34661857-7E24E22F-D74D-43B9-9D66-9993C4B5FA8EQ34946649-E3BB87AA-2381-4285-AAD4-F401FE95B691Q35016946-194FC480-4E46-4219-AC06-BA169190C3F6Q35083552-51ED09FC-9658-45D0-ABE9-DCBFA0FFC7CDQ35399770-663AF944-A4CC-4561-9C59-222419548442Q35478990-C6CEF1E2-5A92-434D-A1BC-972FEC9084BAQ35575585-FF348717-21DC-4529-B4C3-74EF935D3F41Q35796865-91E0B8E2-315F-486B-8A98-1A362FAD32DDQ35861576-4DE6F02D-4724-41A5-BA41-E2B72DCF731AQ36005195-795AC7E4-C057-470E-AD90-4C249A3D642FQ36100579-1CFAB579-51CF-4364-B5F3-076DE7E240E0Q36201283-4AAD7A7F-F28A-40BD-A378-AAF0522F507FQ36388749-B862ECEC-03DF-4020-BE9F-ED7AF4B790D8Q36503369-16B39B7A-F34C-4F34-8766-588E38FDC131Q36746831-4BB35BC4-F95A-472F-8A8B-F66C59A9FAF6Q36790692-9E840E54-8B2F-4B84-81C5-2E033F7E6038Q36895709-9EE52351-6A52-4D9B-AE99-1181B0ABB018Q37074047-C2AAB3F5-8492-48BF-9EC9-D514AECC2086Q37122541-ACC272F0-D39A-4D66-9700-4D5648A31740Q37262639-BFA5AA51-7800-4184-8FC0-0189573D0C8DQ37354516-4C1F58E8-9AB6-41AB-BCC8-86E95A07D969Q37447848-80FE8063-7AC8-4B89-9473-95F7367FD682Q37592171-A74767FD-BBF3-406F-8301-26A0E57343CCQ37821956-4308505E-73FE-4518-A2D8-779746401934Q37890286-3DA7B137-8316-4AC3-9768-EBF3B3F5411EQ37969803-69FE75A4-2C47-4858-9AD3-122F8DEFE173Q37972706-DD8CD635-62C5-4B58-B0C1-DE1A97BD773EQ38002780-DF5836D5-63E8-4736-8860-E0154A3A6ED3Q38132063-E62964D9-AB89-4169-8D3B-BB5A0F74BABB
P2860
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@ast
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@en
type
label
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@ast
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@en
prefLabel
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@ast
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@en
P2093
P2860
P50
P356
P1476
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
@en
P2093
A Karim Kader
David Duggan
Fang-Chi Hsu
Fredrik Wiklund
Jeffrey M Trent
Jielin Sun
John Carpten
Jonas Hugosson
Kathleen E Wiley
P2860
P304
P356
10.1073/PNAS.0914061107
P577
2010-01-11T00:00:00Z